{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:08:54Z","timestamp":1762160934033},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1097\/wno.0b013e3182536558","type":"journal-article","created":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T06:35:30Z","timestamp":1335854130000},"page":"212-215","source":"Crossref","is-referenced-by-count":23,"title":["Safety of Prednisone for Ocular Myasthenia Gravis"],"prefix":"10.1097","volume":"32","author":[{"given":"Beau B.","family":"Bruce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Kupersmith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210126","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2147\/IBPC.S9486","article-title":"Hypertension and other morbidities with Cushings syndrome associated with corticosteroids: a review.","volume":"4","author":"Peppa","year":"2011","journal-title":"Integr Blood Press Control"},{"key":"R2-5-20210126","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/archneur.57.5.752","article-title":"Treatment of ocular myasthenia: steroids only when compelled.","volume":"57","author":"Kaminski","year":"2000","journal-title":"Arch Neurol"},{"key":"R3-5-20210126","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ana.410150316","article-title":"Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients.","volume":"15","author":"Pascuzzi","year":"1984","journal-title":"Ann Neurol"},{"key":"R4-5-20210126","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/archneur.60.2.243","article-title":"Development of generalized disease at 2 years in patients with ocular myasthenia gravis.","volume":"60","author":"Kupersmith","year":"2003","journal-title":"Arch Neurol"},{"key":"R5-5-20210126","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/jnnp.62.2.156","article-title":"Ocular myasthenia gravis: response to long-term immunosuppressive treatment.","volume":"62","author":"Sommer","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R6-5-20210126","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00041327-200312000-00002","article-title":"Immunotherapy of ocular myasthenia gravis reduces conversion to generalized myasthenia gravis.","volume":"23","author":"Mee","year":"2003","journal-title":"J Neuroophthalmol"},{"key":"R7-5-20210126","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1468-1331.2009.02634.x","article-title":"Long-term effects of combined immunosuppressive treatment on myasthenic crisis.","volume":"16","author":"Rozsa","year":"2009","journal-title":"Eur J Neurol"},{"key":"R8-5-20210126","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1212\/01.wnl.0000312373.67493.7f","article-title":"A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis.","volume":"71","year":"2008","journal-title":"Neurology"},{"key":"R9-5-20210126","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ncpneuro0810","article-title":"Steroids and immunosuppressant drugs in myasthenia gravis.","volume":"4","author":"Sathasivam","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"R10-5-20210126","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1212\/01.wnl.0000263481.14289.90","article-title":"Quality Standards Subcommittee of the American Academy of Neurology. Evidence report: the medical treatment of ocular myasthenia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.","volume":"68","author":"Benatar","year":"2007","journal-title":"Neurology"},{"key":"R11-5-20210126","first-page":"213","article-title":"Polymyalgia rheumatica and giant cell arteritis; diagnosis and side effects of low-dose long-term glucocorticoid therapy.","volume":"51","author":"Hatz","year":"1992","journal-title":"Z Rheumatol"},{"key":"R12-5-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0049-0172(91)90051-Z","article-title":"The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis.","volume":"21","author":"Caldwell","year":"1991","journal-title":"Semin Arthritis Rheum"},{"key":"R13-5-20210126","first-page":"123","article-title":"Does early treatment of ocular myasthenia gravis with prednisone reduce progression to generalized diseaseJ Neurol Sci.","volume":"217","author":"Kupersmith","year":"2004","journal-title":""},{"key":"R14-5-20210126","first-page":"249","article-title":"Does early immunotherapy reduce the conversion of ocular myasthenia gravis to generalized myasthenia gravisJ Neuroophthalmol.","volume":"23","author":"Kupersmith","year":"2003","journal-title":""},{"key":"R15-5-20210126","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1749-6632.1976.tb47723.x","article-title":"Oral corticosteroids in the treatment of ocular myasthenia gravis.","volume":"274","author":"Fischer","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"R16-5-20210126","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1212\/WNL.24.8.795","article-title":"Oral corticosteroids in the treatment of ocular myasthenia gravis.","volume":"24","author":"Fischer","year":"1974","journal-title":"Neurology"},{"key":"R17-5-20210126","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/bjo.2004.063404","article-title":"Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.","volume":"89","author":"Kupersmith","year":"2005","journal-title":"Br J Ophthalmol"}],"container-title":["Journal of Neuro-Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNO.0b013e3182536558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:43:27Z","timestamp":1620978207000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041327-201209000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/wno.0b013e3182536558","relation":{},"ISSN":["1070-8022"],"issn-type":[{"value":"1070-8022","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}